Citadel Advisors’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.9K | Sell |
60,400
-1,000
| -2% | -$1.23K | ﹤0.01% | 12260 |
|
|
2025
Q4 | $77.4K | Sell |
61,400
-15,600
| -20% | -$21.7K | ﹤0.01% | 11818 |
|
|
2025
Q3 | $119K | Sell |
77,000
-168,600
| -69% | -$232K | ﹤0.01% | 11716 |
|
|
2025
Q2 | $324K | Sell |
245,600
-91,200
| -27% | -$125K | ﹤0.01% | 9628 |
|
|
2025
Q1 | $559K | Sell |
336,800
-1,064,900
| -76% | -$1.75M | ﹤0.01% | 8245 |
|
|
2024
Q4 | $2.06M | Buy |
1,401,700
+239,400
| +21% | +$366K | ﹤0.01% | 5566 |
|
|
2024
Q3 | $1.73M | Buy |
1,162,300
+636,900
| +121% | +$945K | ﹤0.01% | 5808 |
|
|
2024
Q2 | $657K | Buy |
525,400
+486,800
| +1,261% | +$631K | ﹤0.01% | 7473 |
|
|
2024
Q1 | $46.3K | Sell |
38,600
-94,800
| -71% | -$94.9K | ﹤0.01% | 12238 |
|
|
2023
Q4 | $201K | Buy |
133,400
+76,900
| +136% | +$111K | ﹤0.01% | 9943 |
|
|
2023
Q3 | $90.4K | Buy |
56,500
+2,700
| +5% | +$4.92K | ﹤0.01% | 11022 |
|
|
2023
Q2 | $117K | Sell |
53,800
-800
| -1% | -$1.25K | ﹤0.01% | 10702 |
|
|
2023
Q1 | $79.7K | Sell |
54,600
-98,800
| -64% | -$127K | ﹤0.01% | 11561 |
|
|
2022
Q4 | $192K | Sell |
153,400
-38,800
| -20% | -$61.1K | ﹤0.01% | 10212 |
|
|
2022
Q3 | $363K | Sell |
192,200
-57,100
| -23% | -$135K | ﹤0.01% | 9158 |
|
|
2022
Q2 | $631K | Sell |
249,300
-46,200
| -16% | -$135K | ﹤0.01% | 8127 |
|
|
2022
Q1 | $1.02M | Sell |
295,500
-245,200
| -45% | -$866K | ﹤0.01% | 7657 |
|
|
2021
Q4 | $2.6M | Buy |
540,700
+193,700
| +56% | +$784K | ﹤0.01% | 5621 |
|
|
2021
Q3 | $1.27M | Sell |
347,000
-51,300
| -13% | -$191K | ﹤0.01% | 7527 |
|
|
2021
Q2 | $1.61M | Sell |
398,300
-41,600
| -9% | -$163K | ﹤0.01% | 7136 |
|
|
2021
Q1 | $1.89M | Buy |
439,900
+127,300
| +41% | +$608K | ﹤0.01% | 6523 |
|
|
2020
Q4 | $1.24M | Buy |
312,600
+26,900
| +9% | +$112K | ﹤0.01% | 6344 |
|
|
2020
Q3 | $1.05M | Buy |
285,700
+13,700
| +5% | +$57.8K | ﹤0.01% | 5945 |
|
|
2020
Q2 | $928K | Buy |
272,000
+162,800
| +149% | +$365K | ﹤0.01% | 5976 |
|
|
2020
Q1 | $146K | Sell |
109,200
-56,200
| -34% | -$88.1K | ﹤0.01% | 8319 |
|
|
2019
Q4 | $243K | Buy |
165,400
+117,100
| +242% | +$196K | ﹤0.01% | 7899 |
|
|
2019
Q3 | $101K | Sell |
48,300
-85,600
| -64% | -$175K | ﹤0.01% | 8478 |
|
|
2019
Q2 | $327K | Sell |
133,900
-67,800
| -34% | -$148K | ﹤0.01% | 7448 |
|
|
2019
Q1 | $526K | Sell |
201,700
-116,800
| -37% | -$354K | ﹤0.01% | 6708 |
|
|
2018
Q4 | $959K | Buy |
318,500
+70,300
| +28% | +$238K | ﹤0.01% | 5373 |
|
|
2018
Q3 | $859K | Sell |
248,200
-16,500
| -6% | -$87.6K | ﹤0.01% | 5811 |
|
|
2018
Q2 | $1.24M | Buy |
264,700
+7,500
| +3% | +$28.4K | ﹤0.01% | 4841 |
|
|
2018
Q1 | $815K | Sell |
257,200
-173,700
| -40% | -$699K | ﹤0.01% | 5111 |
|
|
2017
Q4 | $2.11M | Buy |
430,900
+217,200
| +102% | +$1.26M | ﹤0.01% | 3563 |
|
|
2017
Q3 | $1.47M | Buy |
213,700
+14,500
| +7% | +$91.4K | ﹤0.01% | 3792 |
|
|
2017
Q2 | $1.31M | Buy |
199,200
+25,100
| +14% | +$176K | ﹤0.01% | 3711 |
|
|
2017
Q1 | $1.39M | Buy |
174,100
+45,900
| +36% | +$386K | ﹤0.01% | 3526 |
|
|
2016
Q4 | $1.19M | Sell |
128,200
-2,800
| -2% | -$29K | ﹤0.01% | 3630 |
|
|
2016
Q3 | $1.39M | Sell |
131,000
-78,900
| -38% | -$786K | ﹤0.01% | 3430 |
|
|
2016
Q2 | $1.96M | Sell |
209,900
-55,900
| -21% | -$568K | ﹤0.01% | 2769 |
|
|
2016
Q1 | $2.76M | Buy |
265,800
+96,000
| +57% | +$877K | ﹤0.01% | 2327 |
|
|
2015
Q4 | $1.71M | Sell |
169,800
-154,100
| -48% | -$1.54M | ﹤0.01% | 2912 |
|
|
2015
Q3 | $2.72M | Buy |
323,900
+57,200
| +21% | +$757K | ﹤0.01% | 2575 |
|
|
2015
Q2 | $4.29M | Buy |
266,700
+30,100
| +13% | +$468K | ﹤0.01% | 2204 |
|
|
2015
Q1 | $3.35M | Sell |
236,600
-140,400
| -37% | -$1.83M | ﹤0.01% | 2462 |
|
|
2014
Q4 | $3.77M | Sell |
377,000
-128,300
| -25% | -$1.1M | ﹤0.01% | 2249 |
|
|
2014
Q3 | $4.3M | Buy |
505,300
+24,100
| +5% | +$212K | ﹤0.01% | 2121 |
|
|
2014
Q2 | $4.25M | Buy |
481,200
+159,000
| +49% | +$1.39M | ﹤0.01% | 1982 |
|
|
2014
Q1 | $3M | Buy |
322,200
+14,800
| +5% | +$130K | ﹤0.01% | 2222 |
|
|
2013
Q4 | $2.59M | Sell |
307,400
-123,800
| -29% | -$1.25M | ﹤0.01% | 2290 |
|
|
2013
Q3 | $3.8M | Buy |
431,200
+133,300
| +45% | +$1.07M | 0.01% | 1804 |
|
|
2013
Q2 | $2.12M | Buy |
+297,900
| New | +$2.06M | ﹤0.01% | 2436 |
|
Other funds holding OPK
RCMNY
VPM
VCM
WCM
Citadel Advisors's OPK Position: Q1 2026 in Review
Citadel Advisors reduced its Opko Health (OPK) stake by 27% in Q1 2026, selling an estimated $958K and leaving 2,079,547 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #5735.
Citadel Advisors first reported a position in OPK in Q2 2013 and has held it in 51 quarters since. The position peaked at $26.7M in Q2 2020. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.
- Citadel Advisors held 2,079,547 shares of Opko Health worth $2.37M as of Q1 2026.
- Citadel Advisors sold 777,886 Opko Health shares in Q1 2026, an estimated $958K.
- Opko Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #5735 holding.
- Citadel Advisors first reported a position in Opko Health in Q2 2013 and has held it in 51 quarters since.
- Citadel Advisors's Opko Health position peaked at $26.7M in Q2 2020.
- 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.